Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.8M Buy
78,916
+1,150
+1% +$410K 0.35% 72
2025
Q4
$25.5M Sell
77,766
-1,171
-1% -$371K 0.32% 74
2025
Q3
$22.3M Sell
78,937
-152
-0.2% -$44.1K 0.29% 83
2025
Q2
$22.1M Buy
+79,089
New +$22.4M 0.31% 82

Other funds holding AMGN

Midwest Trust's AMGN Position: Q1 2026 in Review

Midwest Trust increased its Amgen (AMGN) stake by 1.5% in Q1 2026, buying an estimated $410K and bringing the position to 78,916 shares worth $27.8M. The position accounts for 0.35% of the portfolio, ranked #72.

Midwest Trust first reported a position in AMGN in Q2 2025 and has held it in 4 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Midwest Trust held 78,916 shares of Amgen worth $27.8M as of Q1 2026.
  • Midwest Trust bought 1,150 Amgen shares in Q1 2026, an estimated $410K.
  • Amgen made up 0.35% of Midwest Trust's portfolio in Q1 2026, its #72 holding.
  • Midwest Trust first reported a position in Amgen in Q2 2025 and has held it in 4 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Midwest Trust's 13F filing for Q1 2026, filed 1 May 2026.